SCHEMBL9895356

SCHEMBL9895356

CC(C)(C)[SiH2]OC(C)(C)c1ccc2nc(N)oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 1/20 0.45
LCK P06239 1/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
CSNK1D P48730 1/20 0.33
CSNK1G2 P78368 1/20 0.33
MTOR P42345 1/20 0.32
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
GFER P55789 1/20 0.32
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
KMT2A Q03164 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179511 0.79 PIK3CG (0.56) PIK3CGLCKMAPTLMNACYP1A2
SCHEMBL21389736 0.74 PIK3CG (0.50) PIK3CGLCKMAPTLMNACYP1A2
SCHEMBL19727247 0.74 PIK3CG (0.50) PIK3CGLCKMAPTLMNACYP1A2
SCHEMBL14131 0.72 PIK3CG (0.56) PIK3CGLCKMAPTLMNACYP1A2
SCHEMBL23582354 0.71 LCK (0.45) PIK3CGLCKMAPTLMNACYP1A2
SCHEMBL5454232 0.71 CYP3A4 (0.42) MAPTTHRBALOX15MAPK1KDM4E
SCHEMBL7234998 0.68 TDP1 (0.39) MAPTMAPK1MEN1ALDH1A1KMT2A
SCHEMBL4406050 0.68 ALDH1A1 (0.44) MAPTCYP1A2ALOX15MAPK1NPC1
SCHEMBL331282 0.67 NOS3 (0.49) KDM4EMEN1KMT2A
SCHEMBL5458120 0.67 CYP3A4 (0.38) MAPTTHRBALOX15MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 PIK3CG 1781/4885LCK 2116/4885MAPT 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.